FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kim Garlinghouse-Jones

Research Profile

Genes & Molecular Sequences

Disorders

Physiology

Phenomena

Polymorphism, Single-Stranded Conformational

Chemicals & Drugs

Procedures

DNA Mutational Analysis

Co-author Network

Publications

TOP 3
Susan J Ramus; Patricia A Harrington; Carole Pye; Richard A DiCioccio; Mark J Cox; Kim Garlinghouse-Jones; Ingrid Oakley-Girvan; Ian J Jacobs; Richard M Hardy; Alice S Whittemore; Bruce A J Ponder; M Steven Piver; Paul D P Pharoah; Simon A Gayther
Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer.
Alice S Whittemore; Raymond R Balise; Paul D P Pharoah; Richard A DiCioccio; Ingrid Oakley-Girvan; Susan J Ramus; M Daly; M B Usinowicz; Kim Garlinghouse-Jones; Bruce A J Ponder; Saundra S Buys; R Senie; Irene L Andrulis; E John; John L Hopper; M Steven Piver
Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations.
Bruce A Werness; Susan J Ramus; Richard A DiCioccio; Alice S Whittemore; Kim Garlinghouse-Jones; Ingrid Oakley-Girvan; Yoshiaki Tsukada; Patricia Harrington; Simon A Gayther; Bruce A J Ponder; M Steven Piver
Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kim Garlinghouse-Jones (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Susan J Ramus; Patricia A Harrington; Carole Pye; Richard A DiCioccio; Mark J Cox; Kim Garlinghouse-Jones; Ingrid Oakley-Girvan; Ian J Jacobs; Richard M Hardy; Alice S Whittemore; Bruce A J Ponder; M Steven Piver; Paul D P Pharoah; Simon A Gayther
Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer.
Human mutation 2007;28(12):1207-15.
2004: Alice S Whittemore; Raymond R Balise; Paul D P Pharoah; Richard A DiCioccio; Ingrid Oakley-Girvan; Susan J Ramus; M Daly; M B Usinowicz; Kim Garlinghouse-Jones; Bruce A J Ponder; Saundra S Buys; R Senie; Irene L Andrulis; E John; John L Hopper; M Steven Piver
Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations.
British journal of cancer 2004;91(11):1911-5.
2004: Bruce A Werness; Susan J Ramus; Richard A DiCioccio; Alice S Whittemore; Kim Garlinghouse-Jones; Ingrid Oakley-Girvan; Yoshiaki Tsukada; Patricia Harrington; Simon A Gayther; Bruce A J Ponder; M Steven Piver
Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2004;23(1):29-34.
2000: Bruce A Werness; Susan J Ramus; Alice S Whittemore; Kim Garlinghouse-Jones; Ingrid Oakley-Girvan; Richard A DiCioccio; Yoshiaki Tsukada; Bruce A J Ponder; M Steven Piver
Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations.
Human pathology 2000;31(11):1420-4.
2000: Bruce A Werness; Susan J Ramus; Alice S Whittemore; Kim Garlinghouse-Jones; Ingrid Oakley-Girvan; Richard A DiCioccio; Yoshiaki Tsukada; Bruce A J Ponder; M Steven Piver
Primary ovarian dysgerminoma in a patient with a germline BRCA1 mutation.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2000;19(4):390-4.
2000: Bruce A Werness; P Parvatiyar; Susan J Ramus; Alice S Whittemore; Kim Garlinghouse-Jones; Ingrid Oakley-Girvan; Richard A DiCioccio; Jonathan S Wiest; Yoshiaki Tsukada; Bruce A J Ponder; M Steven Piver
Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53.
Journal of the National Cancer Institute 2000;92(13):1088-91.